top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
COVID-19 and Gastrointestinal Disease: Current Insights and Future Management
COVID-19 and Gastrointestinal Disease: Current Insights and Future Management
Autore Goyal Hemant
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (184 p.)
Soggetto topico Medicine
Soggetto non controllato COVID-19
liver
non-alcoholic steatohepatitis
transient elastography
mortality
liver disease
clinical manifestations
SARS-CoV-2
gastroenterology
hepatology
endoscopy
delivery of healthcare
acute mesenteric ischemia
thromboemboembolism
endothelitis
cytokines
hypercoagulability
inflammatory bowel disease
gastrointestinal manifestations
abdominal pain
dyspnea
clinical course
upper gastrointestinal bleeding
pandemic
outcomes
anxiety
depression
medication adherence
severity of COVID-19
hospitalized patients
risk factors
SARS-CoV-2 infection
gut dysbiosis
microbiota
gastrointestinal disorders
intestinal inflammation
ACE2 dysregulation
gut microbiota
enteric infection
ISBN 3-0365-6090-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti COVID-19 and Gastrointestinal Disease
Record Nr. UNINA-9910639987503321
Goyal Hemant  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Links between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges: Mechanistic and Therapeutic Challenges
Links between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges: Mechanistic and Therapeutic Challenges
Autore Gabazza Esteban C
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (348 p.)
Soggetto non controllato bleomycin
regeneration
antitumor efficacy
lung cancer
SOX2
leiomyosarcoma
lung cancer (LC)
nanoparticles
cytokines
hepatocellular carcinoma
metabolic reprogramming
hepatic stellate cells
angiogenesis
transforming growth factor-?
anaplastic lymphoma kinase
idiopathic pulmonary fibrosis
growth factor
pathogenesis
cancer-associated fibroblasts
fibrosis
lipopolysaccharide
DHA
lncRNA
SREBP-1
YAP
protein S
non-small cell lung cancer (NSCLC)
omega-3 fatty acid
inflammation
metastasis
clinical symptoms
miRNA
smooth muscle tumor of uncertain malignant potential
Wnt
interstitial fluid pressure
heterogeneity
hepatocytes
myometrium
tumor necrosis factor ?
tumor
tumor microenvironment
extracellular matrix
TAZ
carcinogenesis
cystic formation
pulmonary fibrosis
HBV
cytokine
genetic instability
diagnosis
EMT
crizotinib
Hippo pathway
GPR120
marker
HCV
non-alcoholic steatohepatitis
pathology
common pathways
apoptosis
type I collagen
GPR40
acute lung injury
uterine fibroid
renal injury
pathophysiology
reactive oxygen species
immunohistochemistry
SMAD
butylidenephthalide
leiomyoma
cirrhosis
Erk1/2
targeted therapy
TGF-?
mechanotransduction
therapy
breast cancer
hepatocellular carcinoma (HCC)
hepatic stellate cells (HSCs)
idiopathic pulmonary fibrosis (IPF)
cancer-associated fibroblasts (CAFs)
cancer
signal pathway
tumor stiffness
ISBN 3-03921-707-0
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Links between Fibrogenesis and Cancer
Record Nr. UNINA-9910367745903321
Gabazza Esteban C  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Metabolism and Metabolomics of Liver in Health and Disease
Metabolism and Metabolomics of Liver in Health and Disease
Autore Wahli Walter
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (268 p.)
Soggetto topico Medicine
Soggetto non controllato nonalcoholic fatty liver disease
nonalcoholic steatohepatitis
Fibrosis
Liver biopsy
Genomics
Metabolomics
Proteomics
Transcriptomics
nicotinamide
NAFLD
steatosis
heat stress
primary mouse hepatocytes
metabolic profile
GC-MS
multivariate statistical analysis
arachidonic acid
docosahexaenoic acid
inflammation
fibrosis
lipidomics
mass spectrometry
in vitro
HepaRG
sodium saccharin
reference toxicants
de novo lipogenesis
carbohydrate response element-binding protein
ChREBP
diabetes
glucose production
glycogen
glycolysis
glycogen storage disease type I
hexosamine
pentose phosphate pathway
acupuncture
imflammation
lipid metabolism
oxidative stress
metabolomics quantitative profiling
1H-NMR spectroscopy
liver
bile acids
metabolomics
rat plasma
tandem mass spectrometry
liquid chromatography
acetaminophen
hepatotoxicity
biomarker
premalignant
alcoholic liver disease
cholestasis
cirrhosis
NAFL
NASH
standard operating procedures
urine
blood
feces
tissue
cells
liver function
nonalcoholic fatty liver
liquid chromatography-mass spectrometry
nuclear magnetic resonance spectroscopy
metabolic pathway
non-alcoholic fatty liver disease
non-alcoholic steatohepatitis
transcription factors
metabolic stress
lipid homeostasis
glucose homeostasis
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557148103321
Wahli Walter  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui